Carmen Garnacho Montero

Profesora Titular de Universidad
Área de conocimiento: Biología Celular
Departamento: Citología e Histología Normal y Patológ.
Prog. doctorado: Prog.Doct.en Biología Molecular, Biomedicina e Investigac.Clínica (RD.2011)
Tipo Año Título Fuente
Artículo2017 Enhanced Delivery and Effects of Acid Sphingomyelinase by ICAM-1-Targeted Nanocarriers in Type B Niemann-Pick Disease Mice MOLECULAR THERAPY
Artículo2017 ICAM-1 targeting, intracellular trafficking, and functional activity of polymer nanocarriers coated with a fibrinogen-derived peptide for lysosomal enzyme replacement JOURNAL OF DRUG TARGETING
Artículo2016 A Comparative Study on the Alterations of Endocytic Pathways in Multiple Lysosomal Storage Disorders MOLECULAR PHARMACEUTICS
Artículo2016 Intracellular Drug Delivery: Mechanisms for Cell Entry CURRENT PHARMACEUTICAL DESIGN
Artículo2015 Altered Clathrin-Independent Endocytosis in Type A Niemann-Pick Disease Cells and Rescue by ICAM-1-Targeted Enzyme Delivery MOLECULAR PHARMACEUTICS
Artículo2015 Comparative study of the primary cilia in thyrocytes of adult mammals JOURNAL OF ANATOMY
Artículo2014 Altered Clathrin Dependent and Independent Endocytosis in Lysosomal Storage Disease Cells and Therapeutic Rescue by Storage Attenuation. MOLECULAR BIOLOGY OF THE CELL
Artículo2014 Clathrin-Mediated Endocytosis Is Impaired in Type A-B Niemann-Pick Disease Model Cells and Can Be Restored by ICAM-1-Mediated Enzyme Replacement MOLECULAR PHARMACEUTICS
Ponencia2014 Pulmonary delivery and effects of recombinant acid sphingomyelinase by ICAM-1-targeted nanocarriers in the Niemann-Pick disease mouse model MOLECULAR GENETICS AND METABOLISM
Artículo2013 Comparative binding, endocytosis, and biodistribution of antibodies and antibody-coated carriers for targeted delivery of lysosomal enzymes to ICAM-1 versus transferrin receptor JOURNAL OF INHERITED METABOLIC DISEASE
Artículo2013 Expression of hypothalamic regulatory peptides in thyroid C cells of different mammals GENERAL AND COMPARATIVE ENDOCRINOLOGY
Artículo2013 In vivo performance of polymer nanocarriers dually-targeted to epitopes of the same or different receptors BIOMATERIALS
Artículo2012 A fibrinogen-derived peptide induces clathrin- and caveolae-independent endocytosis in endothelial cells FASEB JOURNAL
Artículo2012 A Fibrinogen-Derived Peptide Provides Intercellular Adhesion Molecule-1-Specific Targeting and Intraendothelial Transport of Polymer Nanocarriers in Human Cell Cultures and Mice JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Artículo2012 Genetic variants of the MBL2 gene are associated with mortality in pneumococcal sepsis DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
Artículo2012 Intercellular Adhesion Molecule 1 Engagement Modulates Sphingomyelinase and Ceramide, Supporting Uptake of Drug Carriers by the Vascular Endothelium ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Artículo2012 Role of ligand size and binding accessibility on clathrin-and caveolae-independent CAM-mediated endocytosis MOLECULAR BIOLOGY OF THE CELL
Artículo2011 CAM-mediated endocytosis contributes to leukocyte transcellular transmigration FASEB JOURNAL
Ponencia2011 Design of ICAM-1-Targeting Strategies for Brain Delivery of Lysosomal Therapies MOLECULAR GENETICS AND METABOLISM
Artículo2011 Enhanced endothelial delivery and biochemical effects of alpha-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease JOURNAL OF CONTROLLED RELEASE
Artículo2010 Acid Sphingomyelinase and Membrane Composition in CAM-Mediated Endocytosis ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Editorial2009 Diagnosis of Prader-Willi syndrome MEDICINA CLINICA
Artículo2008 Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers MOLECULAR THERAPY
Artículo2008 Delivery of acid sphingomyelinase in normal and Niemann-Pick disease mice using intercellular adhesion molecule-1-targeted polymer nanocarriers JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Artículo2008 Differential intra-endothelial delivery of polymer nanocarriers targeted to distinct PECAM-1 epitopes JOURNAL OF CONTROLLED RELEASE
Ponencia2008 Microscopic imaging of oxygen by two-photon-excited phosphorescence Biomedical Optics, BIOMED 2008
Artículo2008 Oxygen microscopy by two-photon-excited phosphorescence CHEMPHYSCHEM
Artículo2008 RhoA activation and actin reorganization involved in endothelial CAM-mediated endocytosis of anti-PECAM carriers: critical role for tyrosine 686 in the cytoplasmic tail of PECAM-1 BLOOD
Artículo2007 Polymorphisms of mitochondrial DNA and mortality in sepsis. Have we found the needle in the haystack? MEDICINA INTENSIVA
Artículo2006 Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis CRITICAL CARE
Revisión2005 Genetic polymorphisms in sepsis MEDICINA INTENSIVA
Artículo2005 Lack of Pwcr1/MBII-85 snoRNA is critical for neonatal lethality in Prader-Willi syndrome mouse models MAMMALIAN GENOME
Artículo2005 Steroid-induced myopathy in patients intubated due to exacerbation of chronic obstructive pulmonary disease INTENSIVE CARE MEDICINE
Letter2004 Restriction fragment length polymorphism method in clinical studies CRITICAL CARE MEDICINE
Artículo2002 Clinical and metabolic effects of two lipid emulsions on the parenteral nutrition of septic patients NUTRITION
Artículo2002 Effects of three intravenous lipid emulsions on the survival and mononuclear phagocyte function of septic rats NUTRITION
Artículo2001 Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients INTENSIVE CARE MEDICINE
Artículo2001 Dos hermanos con síndrome de Prader-Willy por deleción clásica. ¿Es la excepción que confirma la regla? REVISTA DE NEUROLOGIA
Artículo2000 A genetic study of 64 patients clinically suspected of having Angelman's syndrome REVISTA DE NEUROLOGIA
Artículo2000 Neonatal hypotonia in the Prader-Willi syndrome due to t(15;16) REVISTA DE NEUROLOGIA

Proyectos de Investigación

Fecha de inicio Fecha de fin Rol Denominación Agencia financiadora
01/01/2011 31/12/2013 Responsable Terapias dirigidas para el tratamiento del cáncer de tiroides mediante nanopartículas (PI-0280-2010) Consejería de Salud y Bienestar Social (Fundación Progreso y Salud) (Autonómico)
01/01/2014 31/12/2016 Responsable Marcadores de cáncer stem cells en carcinoma microcítico de pulmón: valoración pronóstica y uso como dianas específicas para el desarrollo de terapias avanzadas mediante nanotransportadores dirigidos (PI-0051-2013) Consejería de Salud y Bienestar Social (Fundación Progreso y Salud) (Autonómico)